Smith & Nephew PLC 6-K, filed May 30, 2025
Smith & Nephew PLC (SNN)
6-K
2025-05-30
For: 2025-05-30
View Original
Added on
April 07, 2026
About this 6-K
Smith & Nephew PLC filed this 6-K on May 30, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
May 30,
2025
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate by check
mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Form
20-F ✓
Form 40-F
__
SMITH & NEPHEW PLC
30 May 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse
Regulation (Regulation (EU) 596/2014, as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act
2018).
|
Reason for the notification
|
|
|
Initial notification/Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Purchase of ordinary shares through the Company's Dividend
Re-Investment Plan following the 2024 final dividend payment on 28
May 2025.
|
|
Date of Transaction
|
2025 - 05 - 28
|
|
Place of Transaction
|
London Stock Exchange (XLON)
|
|
Name
(Position)
|
Director / PDMR
|
Price (£)
|
Volume
|
Aggregated information
|
|
Helen Barraclough
(Group General Counsel and Company Secretary)
|
PDMR
|
10.65669
|
803.57057
|
N/A Single Transaction
|
|
Craig Gaffin
(President, Global Orthopaedics)
|
PDMR
|
10.65669
|
331.91224
|
N/A Single Transaction
|
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
10.65669
|
701.28312
|
N/A Single Transaction
|
|
Phil Cowdy
Chief Corporate Development & Corporate Affairs
Officer
|
PDMR
|
10.65669
|
250.51541
|
N/A Single Transaction
|
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
10.65669
|
553.43002
|
N/A Single Transaction
|
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
10.65669
|
3,457.19103
|
N/A Single Transaction
|
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
10.65669
|
93.4531
|
N/A Single Transaction
|
|
Scott Schaffner
(President, Sports Medicine)
|
PDMR
|
10.65669
|
1,327.82169
|
N/A Single Transaction
|
|
Rohit Kashyap
(President, Advanced Wound Management and Global Commercial
Operations)
|
PDMR
|
10.65669
|
332.8502
|
N/A Single Transaction
|
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
10.65669
|
411.65422
|
N/A Single Transaction
|
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
May 30, 2025
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|